Trial Is Testing Cutting-edge Immunotherapy in MS Patients & Making the Most of Limited Energy

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a phase 1/2 clinical trial is evaluating the safety and effectiveness of a cutting-edge immunotherapy called extracorporeal photopheresis in people with MS.He also reads “How I’m Making the Most of My Limited Energy as Someone With MS”, from Jamie Hughes’ column, “A Life in Letters.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/